Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQVkJmZVFjYkR2UzVNWF8yRFh2d2xtRDdtNFRrbVlTMGx6OU0wSEpkSHM2R19neWYzWmV5ZTBmUkNFbVRuYXJNR3dzTHZyU2t1X28zZ3hYUGRGV3pzWEFTTHQ2S0RXOHpzQTBTZW9Oa2d1eVdaS254cUlEN2s3X1FpNUpGOHdmQXhFWHN5X2hRcFRkYWlZLXZyYlJoZmd3QQ?oc=5" target="_blank">FDA Approves First-In-Class Med for Parkinson's Disease</a>&nbsp;&nbsp;<font color="#6f6f6f">Medscape</font>
Adult victims, suspected shooter ID'd in Erie mass shooting
Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air
Al Nassr Asian Champions League clash in doubt over Riyadh security situation
Brexton Busch honors dad Kyle with burnout, signature bow
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9PNGg2d084c2o5Y0x4N0lhbG13U000T0x3NzlHYXkzb3BqT18yU3I1RGJsazhfQXlEcVYwWk1XY3hzVEZVWjdIUmRteFVPb0lseS1DYlJHMEJqWEl6dk10OXJhSU52dUlySkZkMVUtOA?oc=5" target="_blank">First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval</a>&nbsp;&nbsp;<font color="#6f6f6f">MedPage Today</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNN3doYks2Q0RyZUdibGJRSDlXakMwOWNNU2xoeVdKMDRkY0NIVWctVktUM0pwRzVkLURiYUFTVTFjUFFxcVc4djQxQ1c5NXBvd2hBQk9UVGF0TGJQYXpuZ0VtLXdLWm1qQUIySl9wTDloTUd0bk1vVzN0WUg5V0lDaXVTXzBDU0VZU3BPNm5uYnFCY3lzNUtHWUFyVF93WVRyeEVXZ3FhdTdEc2Q2V1ln?oc=5" target="_blank">Scholar Rock wins FDA approval for first drug to target SMA muscle loss</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQMjFOV1dfQTJ2TDlhTU50eXNXR3ZNeW5Bb0Q5WDg4azV4aFZuUlpXQUlRU014WDh6U19vRkd2NVpmRnA0aURkSEk5S0Z1U3FxTFFHTVR0U09fLXFhZWxrSXJUdmxnYW1jOFZpcV82bG54V21wYzJHUE5EYUFzNERNMU9qb2JKbTFfb21LMEpabTBIcmdBN0FvMQ?oc=5" target="_blank">FDA Approves Zilganersen, First Treatment for Alexander Disease</a>&nbsp;&nbsp;<font color="#6f6f6f">NeurologyLive</font>
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxOREhqT1Zma25HNGh4cWtZSWhTVFVkSGxnYWtMb2RtZDVfeWRySWQ1c1pkZFdVLVVFdlRPeVNuRFRDczZxNnk4TXJJT0ZsOU90eXdEVkptbUhwS3B5X0tZYlpabnRtVXM5M1RYZ3NCc0hDRlpxR1JzMEVXRG5xU3prS3F4X0lTNWc2cEwtZDVBUnc1REp3SllWMUttck1xRXlWcEhzUWYtUXdSVlRpQ0NUWHlpRnR4N3NQRDlZREd2Z1pXZlVmNzBCM05neW5Nem1RYTdBSUZxSUtTUC04RmpwMXItSVlpUQ?oc=5" target="_blank">FDA Approves First Ophthalmic Treatment for Wet AMD Leading Wainwright to Triple Price Target</a>&nbsp;&nbsp;<font color="#6f6f6f">Streetwise Reports</font>
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE5JZ3ZWNE50YlE2REhPdkpCN0NQdDB5QXl5OGxvM3psaDhZT3BieXBCVDBHbC1pUzlmSWI3UnFud3dKOFRoY0NCX3hnSDVsQ1ZxTXBQWnhsUldOaVNKSDlmX2RvNzAwQVpaNU1TbTBxajJpLWZrUEZHUjlIclFvZjQ?oc=5" target="_blank">FDA approves first drug for full range of narcolepsy symptoms</a>&nbsp;&nbsp;<font color="#6f6f6f">Medical Xpress</font>
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxQYWZCdzBPZjNWcndUcjNhS1hEREpyREZoRlhqNjlReEJrYi1HTThHQjlZRktFMHIwZkgwUS02Tjd2alZjR3l5MEhndjhJdTktRVp1Y0M5UG5uNDczZlpIaWtzRjFWVlpPYlY3RUZBWEo0OEJZa1lqU0NDTkpkQUJxMEFxU2tRdw?oc=5" target="_blank">FDA approves first drug to treat Alexander’s disease</a>&nbsp;&nbsp;<font color="#6f6f6f">PharmaLive</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOeEUta1VkWGwzNnBPaEFaVjJ4c0RmWU1QY3ZDZjBIU3Exc2MwR19RUzFlaC1KRGcyWXViUXFnanJXc3hZaG1CSWdFdVB0Q05nbmdHaGNlbFZ3TDZJMk02c1ZXR1JGcDZVUG42eXluMmZTSVZJa0lSOTRhVmxXU3ZYN05TNXFNQWhkOFM3ZDFxY082Zmt0bFJYR2NBeU94Zw?oc=5" target="_blank">FDA Approves Isembyld, First SMA Treatment To Target Muscle Loss</a>&nbsp;&nbsp;<font color="#6f6f6f">Dallas Express</font>
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNN3I2SUJTSE9jNWtncFZ6ZVFpMzRTbzM3MHh5WGxCeGhkVlF5QkhEQWZNVVFLMS12LVg3U1dJTE5zV3RtRnpFaG9ON0JCQkxTQjNqT2dNQlZGeC1welU2aWMyR2FzTGJzQlpCaVJEblMtMTBHWVJncWM3SjE2cEtpYU9Eb3A4eUZkUExZemtfano4WFp6aS1SbkdaMm1lU2ltaHdiWm1UcC1vSS1GTUdOZE9KNFJWYzQ2R2Ruc2IxTW80YXJyU2c?oc=5" target="_blank">FDA Approves First Orexin-Targeting Drug for Narcolepsy Type 1</a>&nbsp;&nbsp;<font color="#6f6f6f">Sleep Review</font>
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQWUprcExIS2lGLTZQOFNwVWt6R0FRR00weGtIM2RBanhlNzBaY1U0ZHhSWXdnamtYQTgyQkhFRmp4YXdIQzdielJUX3ZfVmZMLXAyNy1Xbm5ZSFY1MHVHTzh6VXAyNnVjWXhqT3l6WUo4VEN2bUNFbms1Q3VFR1p2cy1zWE9ieW9STEo3SXdoQWdhQ2xFb0ZtcDZ3?oc=5" target="_blank">FDA Approves First PROTAC Therapy for Breast Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharm International</font>
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQYnpPM2o4V3FNeEhiclRhZVNUTnY4U0NPZHNYOHVUc2t3b0U0YkJQVEUyLUZsSzc4Q3FyOWN3RjNjWE1sa3F0U2tpQi01TUo0S3FpT3Z1elVrOW1XNi1HRGFyOVlYLVBiUUZYZzNPQ2NqcHlSOVFGemtkd2lvckpDclJ5a29jS1dhdVJKeU1SWE96Unh1a01sSnQ2Mjl1NF9yd1NXeS1OMjF1T1NaMWtWS1NuRXNIM3lnVVZ3?oc=5" target="_blank">FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxOUkY4MFRyamxCaHh0N2lWeDBKeUhEenNQb3czank0UTE2UGs1YmtEMHJtaGN2N0RCU0FzLTJlUGRicUloUnc2RGdLM1FwdHA5U1BoTzBZMGRnaEE3SzFkbkhfV1E0Njk3VXdQWHpHMExUa1lvSzNuS08tU3lWVWN6a1RVZUtmaVAyWDE5cTBQQlJXdUFEZHVzLUVTYnVZdUFYNGU2NmNjTzZfUnBOd1hNMmFFQ3BjVy01TnV1d09KN001LTVaTlNyS0dJZ2IxSV82OXNIV1lmbFlZUENiRzRJ?oc=5" target="_blank">FDA Approves First Myostatin Inhibitor: What Isembyld Means for the Future of Muscle Growth</a>&nbsp;&nbsp;<font color="#6f6f6f">Muscle & Fitness</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNSERFRnVUOUEyZmMyRElPdUI2RkpKZ3Vza2E2TWFEaWZseUY5T19ndWdoSS0zMlB5RXlRa0xuTVV1VURJcTNmX3lqeU9rWkZiNHdOY09nVk5qbGo0T0lINXhUR3oxanRhWko0N2Z4dEM1S2FMQ3I5WVcwc25vS3d2a2NaUmxXZ0paU3EzQlFzVk1rTDdENWdVcEhnNW1WemJi?oc=5" target="_blank">FDA approves first RAS-targeting drug for pancreatic cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Drug Discovery News</font>
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNam5rbEJIcjlpOWNzQS1qcGtzNnlTa09qemotT1ZjelphZUJoMGJTYVRYWHNZbk1iTmNEQlh3dVpPMVF0SzhjWExXUml3eUNEaXJDSWtHaEFBVTlGZkRNUW1pbW1pTVliVWcwWUEwYnF6MlFxbWsxZ3loemFCNTAxRDFIbnJQNjRLTC1sN1hXc3FWY0ZMeUEzajFOZTJmeF9rc1lya1c3ZjYxUQ?oc=5" target="_blank">FDA Approves First Drug to Treat Alexander Disease</a>&nbsp;&nbsp;<font color="#6f6f6f">finchannel</font>
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPZi1MbVRFSHZ2WTM0eFZaVDkyNktlRTEweTREUzNndmJNekhaOHZzTkhzR2ZkNGcwN2VRSTB3R203ZU5YTmhGOHI4UU1NT1lvLXY5Ym9Qc2F2Sy1TY25ZcXluMXZHN2xNTUhRZnk2LVU2d2F4T0R6Y19oVHZ3amxxWXJHTnZ4VlJJWGttaWJwOWVEV1diTWtldEdLNUhwX0IwSmtHMXBqNmR5aG9vZl9hbQ?oc=5" target="_blank">New High-Potency mRNA Flu Shot for Adults 50 and Over Now Available</a>&nbsp;&nbsp;<font color="#6f6f6f">Everyday Health</font>
<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9ldkt3NmEyWE9wQkhIMi1iWFRzN2x5MV9NZWpTclZCSEdyd0VjdFRtemVYUkdKUEt6OTFuZ3QwTEVaZ3lJcURja3dkU1RrdnRPQlVSVDBqWlgyZ3RQZktnZHVtYzY4cm5fRmc?oc=5" target="_blank">FDA Approves First Neurostimulation Device for PTSD</a>&nbsp;&nbsp;<font color="#6f6f6f">MedCity News</font>
<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxPNEE2NDVzTWVKTWd4eG5kdXRMd2I1eXpHRzZBc0FUc0Y3YTRreF9TQm91NnR6Yk5BWGhPVWNsSW8tWTRsc1RiVFlqX0pEa2VNT0FiUGpwLWFaS0ZjZFNEZjRYcmNycG1aMW9rOGI0QThDRWlaZ3ZzYmIzVTRXaGhzdW4yVHVjV2ZKMURNVDAzdTlka0NSbDNncmlablkxbHdqM3VLbmZuUlJKckd1NThDNmVDTXJ6VWI5Y2pSYjJ2NnVYUUJYdVpJQlk0MjNPUGp5MVVXNndMazlDZTVTMnM0cWkxdWtaRjdrMl9takFkZlB1em1ja0dXX1dnWQ?oc=5" target="_blank">This Newly Approved Narcolepsy Drug Is the First to Target the Sleep Disorder's Root Cause Rather Than Its Symptoms</a>&nbsp;&nbsp;<font color="#6f6f6f">Smithsonian Magazine</font>
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOQ2FnNkw3eVozYmZycmNCMlYwb3FPY2VpaXlhNUQ1a2pJSk1CLUswYVg5VEhlNE91UEVCOS03Zl9zMHc3YnpIX1FCdnV1Y0pTZzYtdzhHeHpJcXpoR2ppWGhGN29NLXNnQ0JrOWZJRl9RODlxeEQwaWphcExZbnQxMlZzVkpRZUdnbHloSHAzd01JRGRzUzM1S1dQYy1UbFMwYmJLU1JhbzAxOEFLbl9LSnJ3?oc=5" target="_blank">Lonvo-z Advances Toward Approval as First In Vivo CRISPR Therapy for Hereditary Angioedema</a>&nbsp;&nbsp;<font color="#6f6f6f">CGTLive®</font>
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPeklRQmpwcE82ci1iMktRa0V1T0JpMDhkUURGRzlCMXhFWnBpQm9ISFhsTTFGU3liTy1idzhVLTgtWi1EWWhsT2I1a0JkOTVrdHZnSzhFbTQ0WDVZSEd2NWdvaVZwdUNUQ2xxLWJ1V3FKXzMwbGtjVHFhc0xZcV9yai1odHpqeGF3c1hRUHFEUEFWdkloTHVEaDZTV3FFS3JxMUE?oc=5" target="_blank">FDA approves first new kind of drug to target gonorrhea in decades</a>&nbsp;&nbsp;<font color="#6f6f6f">STAT</font>
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ05MSFdPUFdWRjJidldGMmVobExVS0xKVDhIbzJHRDlFZVB6T0RCZHBkTTJzYXJqaGRrNXRMR3BQRnQ5RUMtbDIwUkk2T0xOdTVRdW94QmZEbVc3YTRRQ2E5MGFjU1NRN0RoWnBqVkU0bVE0Z29GcTJOMElrTWxTVEhYd3FUcVMzY3VoVUN0akZoaDVjc2JBSVJFdTY4ekxEcjJNSVNxVk9iQlh3SHdYNUk4Ty1IenJJNjVqVTRERjRQRGs?oc=5" target="_blank">FDA Approves Bayer's Lynkuet as First Dual-Target Non-Hormonal Treatment for Menopause Hot Flashes</a>&nbsp;&nbsp;<font color="#6f6f6f">Femtech Insider</font>
<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNb213b3BoQkpIMzdmR3dCTU5nZE12ai0xWUtOOFFhNzFSeFkyUFNwa2dBd2E1MTFpTWh4ZzdsN29mWGN2d0laQTVtOUJHcjR6N0xrUENIYmhiMm1JaElyYzZqbTB4UUdNREJtajBNQ0pjbEJIbWkxQXQxMmJxN1pTdGVsRkFVVVk?oc=5" target="_blank">New menopause drug to target hot flashes without hormones gets FDA approval</a>&nbsp;&nbsp;<font color="#6f6f6f">CNN</font>
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOek5KR1dpS2xuVVlNNk5zbkxreUJXU3ZjMXNoVzV4RG5pend4cmJkMjNTTDM5VHpmVGdzSUFYTjFoSExRTDllallDY2ZUd3hLUFpiMU55UTVBUkVuWkljRV9nZFU3SHZVb1Vvb1FqenRnTkZIU3dpTFdVc2tNMklWendjb01tejRxZFdLY2lnZDdnQmo4?oc=5" target="_blank">FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis</a>&nbsp;&nbsp;<font color="#6f6f6f">The American Journal of Managed Care</font>
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNcnFjTFVkSzl6SldnR1Ayb0FyckJRMnhrSXAtbU13YW5Gc09NOFNnSUE5WXNhVnVvRXlRNjFKWWJtQzF3MEdSUEwzamxKMDdBcFR0RUN2Q0hVY1NZTzg0WlBNRU5qS0xNcFcxcWgtYlI4QUtsY2FvTmtKekNYeXJDUGRMVzhISjhoNW1xWmZldW5xWEZfdTltc3IwcGlMeGMyOXVuX2FXWS1kLUlicF9nUng0V2FaZHZia3VFc0hRWXE0RXc?oc=5" target="_blank">FDA Approves First mRNA Flu Vaccine After High-Profile Reversal | National News | U.S. News</a>&nbsp;&nbsp;<font color="#6f6f6f">U.S. News & World Report</font>
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxQRDZQR1p1dGktdlI0VWxEUXJ4SVRSRzFjTDFiMEhHMGtWQjhlb01nbWxqdEZYVVByR1lKU1ZWOTVaNWF2U2wzMnhKcTZqbVMyUEo5SExNNUMxRHpyOGN0Zm1zOWpQSmY3RF9QdlJwdkdXb2xqcm92bnBPRXo3Yjk3UlVB?oc=5" target="_blank">FDA Approves First Gene Therapy for GSDIa</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPUU9odnJqenJaZjkwQVh0ZmFOZ3JvenpJYkNCdmxoZ1AzR0hDYjZBNUV2elNOTnF5cnNBUDIxZmxqWE1LbmwyX3lnblZZTDlyUG80ejNPZFZGNmV0WGRxaFdWem9yQVZPbmJCQzV0Y0I2RjJrZU43UjJFSncwYTBVdHhDbEs3SlhkVm8ySldHNzIzYUY4QWhhS1hWcnNXRXFMVW5Caw?oc=5" target="_blank">Tezepelumab Becomes First TSLP-Targeting Biologic Approved by FDA for CRSwNP</a>&nbsp;&nbsp;<font color="#6f6f6f">AJMC</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNX0FEU1FDTktMQ0FrNTBiOURiU1VGQWdLZDMwZ2tjVDZ1a0I2Sm81aFVTS0lmM3preDdrLUpGVS1HQml0NjNHNWpyV083VEk5UkwzaU1yQjgydy04WkV6RmVaU2tNRGVyX29mVHRFMXZFMjVVSG1objNkWWhpWE1iQ0VLVFNFZ1JHQmVtSUhkWUxDNFJMTnREcUQwaVU3dFhiVVZteXNfdzVZYU02Mlhz?oc=5" target="_blank">FDA approves Ionis’ antisense drug as first targeted therapy for Alexander disease</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPOUVTOGh0UHdPb09lWEdoSHI5dmxhTGFRcnlJc1RRVTZHcmd1Z3BZUkkxeXk0MnEyUDFXXzFGQW5zZDJQTlhMQ2U2RDYyWG1nZEF5b3hpTW1fbXh3U2xRMzNuQ1pXWE1SWkt5SEJ3LVhNbjNaSmhQZUtLcXZXNndMb1g4c1M5MHBsd1NFclFSSXppZi01cUVtYnUxTUZMWmhvVGxXYjVCSkpnaDRhYWtRanFFQjMwMlNUMHQ4NnFJdzNtSUQ5UFhRR3FIakU?oc=5" target="_blank">US FDA approves first-line use of Boehringer Ingelheim's lung cancer drug</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNaW8yRWZWV3JEZFppVmNsZV9tN0k0OU5xZGxLQWpBTkpLZEg2Z25pNWxLVDhwWlF1WV9kcEhPRmkwa3VKeDlLbjFaNk9lS3l2T0tiT2M5TDBkYTBBLWFmTnhnMTB3T3JXMlJYcDhERURRU0hxQVlVWjlDZEF4ZzdpcWcwQXFXQlBIcklBNURQX3NYN1JWTjlfRmNybWtCdw?oc=5" target="_blank">FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma</a>&nbsp;&nbsp;<font color="#6f6f6f">National Cancer Institute (.gov)</font>
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQU2UxQzBpdkxKNnU3dXF6N1k1Z1RueVZvdWlrRjh1ZV9tQkFGSmNNY25YRU1URjRZSWNTbE1BUVpSR2dMN0c2UjdXd0FVN0FFQUxmS0xpOGRudnJ1N2RUODNqeVE2ZmtVMUZlbDFMRW1VYnRkRXhSV0xlcjFEcjdmTFRJb196OVBQc2tXaG8xNjY0NG5qano3aExuY0piLVU?oc=5" target="_blank">FDA Approves Apitegromab-mstn, First Muscle-Targeted SMA Therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNcmh1M1pkRVFyQl9wTmx0QXVJeWVrVEpTSDFvSWdad2NNTVBudnM5djh4YWpyUEczZTNBUzNzTG8yRjcxaXdaVWRJckZaeWNiTFdHNWxhXzEwMWZwNTBKb25WNHdHdzFBdGhuVklhSjB3b01iQkp0UWRyUTBVMWp4YnBvcVd3aElBV3lmWUlvR3MwemNsczRKbjZBZTJoR09KbWhOdTFxQXlzU2NreEU4RmtZMEw?oc=5" target="_blank">FDA Approves Deucravacitinib as First TYK2 Inhibitor for Psoriatic Arthritis</a>&nbsp;&nbsp;<font color="#6f6f6f">Dermatology Times</font>